Search Results - "Torasawa M"

Germline variants of the POLH and RAD51 genes are candidate variants associated with risk of hormone receptor-negative young-onset breast cancer.

Authors: Yazaki S Kitadai R Momozawa Y et al.

Corporate Authors: Yazaki S Kitadai R Momozawa Y et al.

Source: NPJ breast cancer [NPJ Breast Cancer] 2025 Nov 28; Vol. 11 (1), pp. 133. Date of Electronic Publication: 2025 Nov 28.

Publication Type: Journal Article

Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Chromosome 15q15 Deletion Drives Brain Metastasis in NSCLC.

Authors: Miyakoshi J Shiraishi K Mochizuki A et al.

Source: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2026 Apr; Vol. 21 (4), pp. 103511. Date of Electronic Publication: 2025 Nov 07.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE

Identification of poor prognostic factors using circulating extracellular vesicles in durvalumab consolidation therapy for locally advanced non-small cell lung cancer.

Authors: Utsumi H Yagishita S Kawajiri K et al.

Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2025 Oct; Vol. 208, pp. 108732. Date of Electronic Publication: 2025 Sep 04.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

Tumor Inflammation-Associated Neurotoxicity Masquerading as Severe Immune Effector Cell-Associated Neurotoxicity Syndrome in a Patient With SCLC Treated With Tarlatamab: A Case Report.

Authors: Torasawa M Shukuya T Huang J et al.

Source: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2026 Mar 18, pp. 103649. Date of Electronic Publication: 2026 Mar 18.

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE

Implications of EGFR expression on EGFR signaling dependency and adaptive immunity against EGFR-mutated lung adenocarcinoma.

Authors: Torasawa M Yoshida T Shiraishi K et al.

Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2025 Apr; Vol. 202, pp. 108494. Date of Electronic Publication: 2025 Mar 11.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

Genomic Profiles of Pathogenic and Moderate-Penetrance Germline Variants Associated With Risk of Early-Onset Lung Adenocarcinoma.

Authors: Cho H Shiraishi K Sunami K et al.

Corporate Authors: Cho H Shiraishi K Sunami K et al.

Source: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2025 Nov; Vol. 20 (11), pp. 1626-1638. Date of Electronic Publication: 2025 Jun 15.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE

Clinical and molecular characteristics associated with high PD-L1 expression in EGFR-mutated lung adenocarcinoma.

Authors: Slomka, Jeremy Berthou, Hugo Mansuet-Lupo, Audrey et al.

Source: PLoS ONE. 11/7/2024, Vol. 19 Issue 11, p1-13. 13p.

Osimertinib-Induced Hepatitis Following Immunotherapy in a Patient with Lung Adenocarcinoma Harboring De Novo EGFR Exon 19 Deletion and T790M Mutations: A Case Report.

Authors: Steiner, Bradley Edmond, Amanda Camou, Monica et al.

Source: Reports (MDPI AG). Sep2025, Vol. 8 Issue 3, p101. 7p.

The Spatial Proximity of CD8 + FoxP3 + PD-1 + Cells to Tumor Cells: A More Accurate Predictor of Immunotherapy Outcomes in Advanced Non-Small-Cell Lung Cancer.

Authors: Hu, Zijuan Hu, Zhihuang Chen, Keji et al.

Source: Current Oncology. May2025, Vol. 32 Issue 5, p262. 18p.

Safety and efficacy of programmed cell death-1 inhibitors in relapsed immune-privileged site lymphoma: A systematic review and meta-analysis.

Authors: Uawithya, Ekdanai Kulchutisin, Kamolchanok Jitprapaikulsan, Jiraporn et al.

Source: PLoS ONE. 4/29/2025, Vol. 20 Issue 4, p1-14. 14p.

Association between lorlatinib blood concentration and adverse events and clinical impact of dose modification.

Authors: Igawa Y Yoshida T Makihara R et al.

Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2024 Oct; Vol. 196, pp. 107954. Date of Electronic Publication: 2024 Sep 12.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

Therapeutic Drug Monitoring and Model-Informed Precision Dosing of Oral TKIs and PARP Inhibitors: A Practical Framework for Clinical Implementation.

Authors: Torrent-Rodríguez A Bastida C Martín ECS et al.

Source: Clinical pharmacokinetics [Clin Pharmacokinet] 2026 Jun 12. Date of Electronic Publication: 2026 Jun 12.

Publication Type: Journal Article; Review

Journal Info: Publisher: Country of Publication: Switzerland NLM ID: 7606849 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1926 (Electronic) Linking ISSN: 03125963 NLM ISO Abbreviation: Clin Pharmacokinet Subsets: MEDLINE

Indirect Comparison of the Efficacy of Pembrolizumab Versus Nivolumab as Adjuvant Options for Stage IIB/IIC Melanoma.

Authors: Andreikos DA Argyropoulou I Theocharopoulos C et al.

Source: Targeted oncology [Target Oncol] 2026 May; Vol. 21 (3), pp. 421-432. Date of Electronic Publication: 2026 May 08.

Publication Type: Journal Article; Comparative Study

Journal Info: Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE

Clinical significance of inter-assay discrepancy in PD-L1 evaluation for the efficacy of pembrolizumab in advanced NSCLC with high PD-L1 expression.

Authors: Miyakoshi J Yoshida T Kashima J et al.

Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2024 May; Vol. 191, pp. 107788. Date of Electronic Publication: 2024 Apr 06.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

Optimizing Anti-PD1 Immunotherapy: An Overview of Pharmacokinetics, Biomarkers, and Therapeutic Drug Monitoring.

Authors: Monteiro, Joaquim Faria Fernandes, Alexandrina Tato, Diogo Gavina et al.

Source: Cancers. Oct2025, Vol. 17 Issue 19, p3262. 26p.

Continuation of same programmed death-1 inhibitor regime beyond progression is a novel option for advanced gastric cancer.

Authors: Li, Jiasong Ding, Fang Zhang, Shasha et al.

Source: BMC Cancer. 10/18/2024, Vol. 24 Issue 1, p1-11. 11p.

Rapid Response to Lenvatinib and Disease Flare After Discontinuation in a Patient With Thymic Carcinoma Harboring KIT Exon 11 Mutation: A Case Report.

Authors: Torasawa M Yoshida T Shiraishi K et al.

Source: JTO clinical and research reports [JTO Clin Res Rep] 2024 Feb 28; Vol. 5 (4), pp. 100657. Date of Electronic Publication: 2024 Feb 28 (Print Publication: 2024).

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101769967 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-3643 (Electronic) Linking ISSN: 26663643 NLM ISO Abbreviation: JTO Clin Res Rep Subsets: PubMed not MEDLINE

High density and proximity of CD8⁺T cells to tumor cells are correlated with better response to nivolumab treatment in metastatic pleural mesothelioma.

Authors: Yin, Yuting Sakakibara, Rie Honda, Takayuki et al.

Source: Thoracic Cancer. Jul2023, Vol. 14 Issue 20, p1991-2000. 10p.

Association between immune-related adverse events and therapeutic outcomes in patients with advanced non-small cell lung cancer treated with pembrolizumab: A retrospective study.

Authors: TALAB, TABARAK J. ALI SHAFI, FARHA A. JASIM, SABA M.

Source: World Academy of Sciences Journal. Sep/Oct2025, Vol. 7 Issue 5, p1-9. 9p.

Lymphangioleiomyomatosis: A Review.

Authors: Bouanzoul, Mohammed Amine Rosen, Yale

Source: Archives of Pathology & Laboratory Medicine. Aug2025, Vol. 149 Issue 8, p775-788. 14p.